Article
Novel Insights into the Relationship Between Glucose-Lowering Drugs and Nonalcoholic Fatty Liver Disease and liver function: a Mendelian Randomization Study
2024-08-13
Abstract excerpt
<title>Abstract</title> <p>Objectives The potential risk of nonalcoholic fatty liver disease (NAFLD) and liver toxicity attributed to glucose-lowering medications is uncertain. The objective of this study was to explore the causal relationship between these factors through the implementation of a Mendelian randomization (MR) analysis. Methods Two-sample MR, summary-data-based MR (SMR), and colocalization analys...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dc769fe5-34b8-5f3c-8c46-d452283b587f
- DOI
- 10.21203/rs.3.rs-4759170/v1
